Outcomes measures in idiopathic intracranial hypertension

Research output: Contribution to journalArticlepeer-review

87 Downloads (Pure)

Abstract

Introduction

Idiopathic Intracranial Hypertension is condition characterised by raised intracranial pressure, papilledema, and normal neuroimaging (aside from radiological signs of raised intracranial pressure). Symptoms of idiopathic intracranial hypertension include chronic headaches and for some, visual loss. New treatments are an unmet clinical need.

Areas covered

The aim of this review is to present the evidence base and considered opinion on outcome measures to determine successful management of idiopathic intracranial hypertension.

Expert opinion

Less invasive measures of disease activity such as optical coherence tomography will continue to grow in this field, both as a measure of papilledema, and potentially as a surrogate for intracranial pressure and visual function. As a highly disabling aspect of the disease is headache, treatment outcomes for headache morbidity need to be appropriately chosen and standardized to allow comparison between trials.
Original languageEnglish
Pages (from-to)687-700
JournalExpert Review of Neurotherapeutics
Volume21
Issue number6
Early online date28 May 2021
DOIs
Publication statusE-pub ahead of print - 28 May 2021

Keywords

  • Idiopathic intracranial hypertension
  • headache
  • intracranial pressure
  • obesity
  • optical coherence tomography
  • papilledema
  • pseudotumour cerebri
  • randomized control trial
  • vision and weight loss

ASJC Scopus subject areas

  • General Neuroscience
  • Clinical Neurology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Outcomes measures in idiopathic intracranial hypertension'. Together they form a unique fingerprint.

Cite this